Dr. Saraf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1740 W Taylor St
Dept 3462
Chicago, IL 60612Phone+1 312-704-2885Fax+1 312-704-2737
Education & Training
- University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 2009 - 2012
- MedStar Health Georgetown UniversityFellowship, Hematology and Medical Oncology, 2007 - 2007
- Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
- IL State Medical License 2005 - 2026
- DC State Medical License 2007 - 2008
- American Board of Internal Medicine Hematology
Clinical Trials
- A Voxelotor for Sickle Cell Anemia Patients at Highest Risk for Progression of Chronic Kidney Disease Start of enrollment: 2021 Mar 16
- A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises Start of enrollment: 2021 Oct 04
Roles: Principal Investigator
Publications & Presentations
PubMed
- Kidney function after nonmyeloablative hematopoietic cell transplant for sickle cell disease.Emily Limerick, Matthew M Hsieh, Mauricio Barretto, Neal Jeffries, Clarissa Diamantidis
Bone Marrow Transplantation. 2025-03-22 - Diabetes Mellitus and APOL1 Genotype Increase the Risk for Chronic Kidney Disease Progression in Sickle Cell Disease.Ryan Sun, Anand Srivastava, Joseph L Zapater, Franklin Njoku, Jin Han
Blood. 2025-03-20 - Steady-State Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity Predicts Low Platelet Count at Hospitalization for Sickle Cell Disease Vaso-Occlusive Episodes.Xu Zhang, Binal N Shah, Jin Han, José A López, Dominic W Chung
American Journal of Hematology. 2025-02-17
Abstracts/Posters
- Phase 1 Single (SAD) and Multiple Ascending Dose (MAD) Studies of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of FT-4202, an Allosteric A...Santosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell DiseaseSantosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Risk Factors for Kidney Disease in Hb SC and Hb S_+-Thalassemia Sickle Cell DiseaseSantosh L. Saraf, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- Manifestations of Reduced Kidney Function Occur at a Higher Estimated Glomerular Filtration Rate in Sickle Cell Anemia61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Laboratory and Translational Hematology61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Regulatory Genetic Variation at the S100B Gene Associates with Vaso-Occlusive Manifestations in Sickle Cell Disease2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- TN Doctor Leading $3 Million AI Study for Predicting Kidney Function Decline in Sickle Cell PatientsOctober 30th, 2021
- Alpha-1-Microglobulin and Acute Kidney Injury Associated with Sickle Cell DiseaseApril 7th, 2020
- A Dire DiagnosisMarch 15th, 2019
- Join now to see all
Grant Support
- Mentoring & Patient-Oriented Research in Sickle Cell-Related Kidney DiseaseUNIVERSITY OF ILLINOIS AT CHICAGO2024–2029
- Mentoring & Patient-Oriented Research in Sickle Cell-Related Kidney DiseaseUNIVERSITY OF ILLINOIS AT CHICAGO2024–2029
- Mentoring & Patient-Oriented Research in Sickle Cell-Related Kidney DiseaseUNIVERSITY OF ILLINOIS AT CHICAGO2024–2029
- Clonal hematopoiesis and inherited genetic variation in sickle cell diseaseVANDERBILT UNIVERSITY MEDICAL CENTER2023–2027
- Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)UNIVERSITY OF TENNESSEE HEALTH SCI CTR2021–2026
- Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)UNIVERSITY OF TENNESSEE HEALTH SCI CTR2021–2026
- Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)UNIVERSITY OF TENNESSEE HEALTH SCI CTR2021–2026
- Pathways of Cell-Free Hemoglobin in Sickle Cell NephropathyUNIVERSITY OF ILLINOIS AT CHICAGO2020–2025
- Pathways of Cell-Free Hemoglobin in Sickle Cell NephropathyUNIVERSITY OF ILLINOIS AT CHICAGO2020–2025
- Pathways of Cell-Free Hemoglobin in Sickle Cell NephropathyUNIVERSITY OF ILLINOIS AT CHICAGO2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: